Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Bunn

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Contemporary Clinical Trials|January 17, 2017
Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trialsJianchang Lin, Veronica Bunn
Contemporary Clinical Trials|September 17, 2020
Flexible Bayesian subgroup analysis in early and confirmatory trialsVeronica Bunn, Rachael Liu, Junjing Lin, et al.
Journal of Biopharmaceutical Statistics|June 23, 2022
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analysesJane Pan, Veronica Bunn, Bradley Hupf, et al.
Statistics in Medicine|April 14, 2021
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trialsBradley Hupf, Veronica Bunn, Jianchang Lin, et al.
Statistics in Medicine|June 14, 2021
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical dataMeizi Liu, Veronica Bunn, Bradley Hupf, et al.
Journal of Biopharmaceutical Statistics|April 2, 2024
Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level dataBradley Hupf, Yunlong Yang, Ryan Gryder, et al.
Therapeutic Innovation & Regulatory Science|March 4, 2023
Evolution of Phase II Oncology Trial Design: from Single Arm to Master ProtocolZiji Yu, Liwen Wu, Veronica Bunn, et al.
Biometrics|April 14, 2020
Bayesian analysis of survival data with missing censoring indicatorsNaomi C Brownstein, Veronica Bunn, Luis M Castro, et al.
Journal of Biopharmaceutical Statistics|March 5, 2020
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strataMo Li, Rachael Liu, Jianchang Lin, et al.
JAMA Oncology|October 14, 2021
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical TrialCaicun Zhou, Suresh S Ramalingam, Tae Min Kim, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Contemporary Clinical Trials|January 17, 2017
Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trialsJianchang Lin, Veronica Bunn
Contemporary Clinical Trials|September 17, 2020
Flexible Bayesian subgroup analysis in early and confirmatory trialsVeronica Bunn, Rachael Liu, Junjing Lin, et al.
Journal of Biopharmaceutical Statistics|June 23, 2022
Bayesian Additive Regression Trees (BART) with covariate adjusted borrowing in subgroup analysesJane Pan, Veronica Bunn, Bradley Hupf, et al.
Statistics in Medicine|April 14, 2021
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trialsBradley Hupf, Veronica Bunn, Jianchang Lin, et al.
Statistics in Medicine|June 14, 2021
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical dataMeizi Liu, Veronica Bunn, Bradley Hupf, et al.
Journal of Biopharmaceutical Statistics|April 2, 2024
Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level dataBradley Hupf, Yunlong Yang, Ryan Gryder, et al.
Therapeutic Innovation & Regulatory Science|March 4, 2023
Evolution of Phase II Oncology Trial Design: from Single Arm to Master ProtocolZiji Yu, Liwen Wu, Veronica Bunn, et al.
Biometrics|April 14, 2020
Bayesian analysis of survival data with missing censoring indicatorsNaomi C Brownstein, Veronica Bunn, Luis M Castro, et al.
Journal of Biopharmaceutical Statistics|March 5, 2020
Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strataMo Li, Rachael Liu, Jianchang Lin, et al.
JAMA Oncology|October 14, 2021
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical TrialCaicun Zhou, Suresh S Ramalingam, Tae Min Kim, et al.
Pageof 2